Fræðigrein

Læknablaðið 2007; 93: 299-301

New drugs for age related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with wet age related macular degeneration